Clinical epigenetics · 2026
Mendelian randomization reveals DNA methylation-related pyroptosis genes associated with psoriasis risk.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dong Wenwu, Shi Cuiping
Аннотация
BACKGROUND: Research has indicated a connection between pyroptosis and psoriasis, yet the specific genes involved remain largely unidentified. This study employed Mendelian randomization (MR) to evaluate the potential causal impact of both pyroptosis-related genes and DNA methylation signatures on psoriasis risk.
METHODS: Pyroptosis-related genes were sourced from the GeneCards database. We integrated quantitative trait locus (QTL) data, including expression (eQTLs), DNA methylation (mQTLs), and protein expression (pQTLs). The GCST90014456 database provided genome-wide association study (GWAS) data for psoriasis, using the FinnGen and UKB cohorts for validation. Summary data-based Mendelian randomization (SMR) analysis assessed interactions between these genes and psoriasis, while colocalization analysis identified shared causal genetic variants.
RESULTS: SMR analysis identified 82 methylation sites, 18 gene, and 2 protein were associated with psoriasis risk. Multi-omics integration highlighted ADAR, which increased methylation at cg27530370 was associated with decreased ADAR expression (OR = 0.505, 95% CI [0.421-0.607]). Additionally, DNMT3B, PROM2, and KIF11 were the intersection genes of mQTL and eQTL analysis, and were validated by the UKB cohort in eQTL analysis, and NFKB1 was validated by the UKB cohort in pQTL analysis.
CONCLUSION: This multi-omics analysis reveals that pyroptosis-related genes, particularly ADAR, DNMT3B, PROM2, KIF11, and NFKB1, may be involved in psoriasis development, providing important insights into its molecular mechanisms and potential therapeutic targets.
METHODS: Pyroptosis-related genes were sourced from the GeneCards database. We integrated quantitative trait locus (QTL) data, including expression (eQTLs), DNA methylation (mQTLs), and protein expression (pQTLs). The GCST90014456 database provided genome-wide association study (GWAS) data for psoriasis, using the FinnGen and UKB cohorts for validation. Summary data-based Mendelian randomization (SMR) analysis assessed interactions between these genes and psoriasis, while colocalization analysis identified shared causal genetic variants.
RESULTS: SMR analysis identified 82 methylation sites, 18 gene, and 2 protein were associated with psoriasis risk. Multi-omics integration highlighted ADAR, which increased methylation at cg27530370 was associated with decreased ADAR expression (OR = 0.505, 95% CI [0.421-0.607]). Additionally, DNMT3B, PROM2, and KIF11 were the intersection genes of mQTL and eQTL analysis, and were validated by the UKB cohort in eQTL analysis, and NFKB1 was validated by the UKB cohort in pQTL analysis.
CONCLUSION: This multi-omics analysis reveals that pyroptosis-related genes, particularly ADAR, DNMT3B, PROM2, KIF11, and NFKB1, may be involved in psoriasis development, providing important insights into its molecular mechanisms and potential therapeutic targets.